Ingenza’s Ian Fotheringham recognized with prestigious Charles Tennant Memorial Lecture award

Ingenza is proud to announce that Managing Director Ian Fotheringham has been recognized with one of SCI Scotland’s most prestigious honors – the Charles Tennant Memorial Lecture award – acknowledging his expertise and knowledge in chemical research.

SCI is a long-established and well-respected scientific organization that aims to further the application of chemistry-related sciences for the benefit of the public.

Ian has been chosen to deliver this lecture in appreciation of his influence on the development of numerous and exciting technologies across the chemicals, pharmaceuticals, food and fuel industries at Ingenza.

Ian will be presented with the accolade – which is only awarded once every few years – at the close of IBioIC19, IBioIC’s 5th Annual Conference, which will take place on the 30th and 31st of January 2019 in the Technology and Innovation Centre, Glasgow. His seminar will follow, entitled: “Adapt, survive and thrive – how biotech companies can learn from nature”.

This lecture will explore Ingenza’s deployment of chemo-enzymatic chemical synthesis and synthetic biology in industrial biotechnology applications ranging from sustainable plastics manufacturer to blood coagulation disorders, antimicrobial peptide discovery, and novel medical devices and diagnostics.

I am honored to receive this award and to have the opportunity to present some of Ingenza’s work at the well-respected Charles Tennant Memorial Lecture. We work incredibly hard to develop innovative and inspiring technologies, and myself and the entire team are delighted to be acknowledged in this way.”

Ian Fotheringham

Source: https://www.ingenza.com/ingenzas-ian-fotheringham-to-present-the-charles-tennant-memorial-lecture/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients